Zimmer Biomet Holdings Debt Issuance Proceeds decreased by 57.4% to $744.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.3%, from $700.00M to $744.00M. Over 2 years (FY 2021 to FY 2023), Debt Issuance Proceeds shows a downward trend with a -44.1% CAGR.
An increase indicates successful access to capital markets for expansion or refinancing, while a decrease may suggest a focus on deleveraging or limited market access.
This metric tracks the total cash proceeds received from the issuance of long-term or short-term debt instruments. It re...
Large-cap companies frequently issue debt to optimize their cost of capital; peers monitor this to maintain investment-grade credit ratings.
debt_issuance| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $399.95M | $399.95M | $399.95M | $100.00M | $120.00M | $0.00 | $375.00M | $370.00M | $200.00M | -$570.00M | $499.80M | $700.00M | $736.30M | $1.75B | $744.00M |
| QoQ Change | — | +0.0% | +0.0% | -75.0% | +20.0% | -100.0% | — | -1.3% | -45.9% | -385.0% | +187.7% | +40.1% | +5.2% | +137.4% | -57.4% |
| YoY Change | — | — | — | — | -70.0% | -100.0% | -6.2% | +270.0% | +66.7% | — | +33.3% | +222.8% | +47.3% | — | +6.3% |